Global Inactivated Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 01 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Inactivated Influenza Vaccine market size is expected to reach $ 10170 million by 2029, rising at a market growth of 5.1% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Inactivated Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Inactivated Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Inactivated Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Inactivated Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Inactivated Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Inactivated Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Inactivated Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Inactivated Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Limited, GSK, Sanofi Pasteur, Viatris, Hualan Biological, AstraZeneca, Sinovac Biotech, Aleph Biomedical and Abbott Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Influenza Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Inactivated Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Inactivated Influenza Vaccine Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Inactivated Influenza Vaccine Market, Segmentation by Application
Children
Adolescence
Adults
Elderly

Companies Profiled:
CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered
1. How big is the global Inactivated Influenza Vaccine market?
2. What is the demand of the global Inactivated Influenza Vaccine market?
3. What is the year over year growth of the global Inactivated Influenza Vaccine market?
4. What is the production and production value of the global Inactivated Influenza Vaccine market?
5. Who are the key producers in the global Inactivated Influenza Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Inactivated Influenza Vaccine Introduction
    1.2 World Inactivated Influenza Vaccine Supply & Forecast
        1.2.1 World Inactivated Influenza Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Inactivated Influenza Vaccine Production (2018-2029)
        1.2.3 World Inactivated Influenza Vaccine Pricing Trends (2018-2029)
    1.3 World Inactivated Influenza Vaccine Production by Region (Based on Production Site)
        1.3.1 World Inactivated Influenza Vaccine Production Value by Region (2018-2029)
        1.3.2 World Inactivated Influenza Vaccine Production by Region (2018-2029)
        1.3.3 World Inactivated Influenza Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Inactivated Influenza Vaccine Production (2018-2029)
        1.3.5 Europe Inactivated Influenza Vaccine Production (2018-2029)
        1.3.6 China Inactivated Influenza Vaccine Production (2018-2029)
        1.3.7 Japan Inactivated Influenza Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Inactivated Influenza Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Inactivated Influenza Vaccine Major Market Trends

2 Demand Summary
    2.1 World Inactivated Influenza Vaccine Demand (2018-2029)
    2.2 World Inactivated Influenza Vaccine Consumption by Region
        2.2.1 World Inactivated Influenza Vaccine Consumption by Region (2018-2023)
        2.2.2 World Inactivated Influenza Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Inactivated Influenza Vaccine Consumption (2018-2029)
    2.4 China Inactivated Influenza Vaccine Consumption (2018-2029)
    2.5 Europe Inactivated Influenza Vaccine Consumption (2018-2029)
    2.6 Japan Inactivated Influenza Vaccine Consumption (2018-2029)
    2.7 South Korea Inactivated Influenza Vaccine Consumption (2018-2029)
    2.8 ASEAN Inactivated Influenza Vaccine Consumption (2018-2029)
    2.9 India Inactivated Influenza Vaccine Consumption (2018-2029)

3 World Inactivated Influenza Vaccine Manufacturers Competitive Analysis
    3.1 World Inactivated Influenza Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Inactivated Influenza Vaccine Production by Manufacturer (2018-2023)
    3.3 World Inactivated Influenza Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Inactivated Influenza Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Inactivated Influenza Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Inactivated Influenza Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Inactivated Influenza Vaccine in 2022
    3.6 Inactivated Influenza Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Inactivated Influenza Vaccine Market: Region Footprint
        3.6.2 Inactivated Influenza Vaccine Market: Company Product Type Footprint
        3.6.3 Inactivated Influenza Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Inactivated Influenza Vaccine Production Value Comparison
        4.1.1 United States VS China: Inactivated Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Inactivated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Inactivated Influenza Vaccine Production Comparison
        4.2.1 United States VS China: Inactivated Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Inactivated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Inactivated Influenza Vaccine Consumption Comparison
        4.3.1 United States VS China: Inactivated Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Inactivated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Inactivated Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Inactivated Influenza Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023)
    4.5 China Based Inactivated Influenza Vaccine Manufacturers and Market Share
        4.5.1 China Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Inactivated Influenza Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023)
    4.6 Rest of World Based Inactivated Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Inactivated Influenza Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Inactivated Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Inactivated Influenza Vaccine Production by Type (2018-2029)
        5.3.2 World Inactivated Influenza Vaccine Production Value by Type (2018-2029)
        5.3.3 World Inactivated Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Inactivated Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Children
        6.2.2 Adolescence
        6.2.3 Adults
        6.2.4 Elderly
    6.3 Market Segment by Application
        6.3.1 World Inactivated Influenza Vaccine Production by Application (2018-2029)
        6.3.2 World Inactivated Influenza Vaccine Production Value by Application (2018-2029)
        6.3.3 World Inactivated Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 CSL Limited
        7.1.1 CSL Limited Details
        7.1.2 CSL Limited Major Business
        7.1.3 CSL Limited Inactivated Influenza Vaccine Product and Services
        7.1.4 CSL Limited Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 CSL Limited Recent Developments/Updates
        7.1.6 CSL Limited Competitive Strengths & Weaknesses
    7.2 GSK
        7.2.1 GSK Details
        7.2.2 GSK Major Business
        7.2.3 GSK Inactivated Influenza Vaccine Product and Services
        7.2.4 GSK Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 GSK Recent Developments/Updates
        7.2.6 GSK Competitive Strengths & Weaknesses
    7.3 Sanofi Pasteur
        7.3.1 Sanofi Pasteur Details
        7.3.2 Sanofi Pasteur Major Business
        7.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Product and Services
        7.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Sanofi Pasteur Recent Developments/Updates
        7.3.6 Sanofi Pasteur Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Inactivated Influenza Vaccine Product and Services
        7.4.4 Viatris Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 Hualan Biological
        7.5.1 Hualan Biological Details
        7.5.2 Hualan Biological Major Business
        7.5.3 Hualan Biological Inactivated Influenza Vaccine Product and Services
        7.5.4 Hualan Biological Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Hualan Biological Recent Developments/Updates
        7.5.6 Hualan Biological Competitive Strengths & Weaknesses
    7.6 AstraZeneca
        7.6.1 AstraZeneca Details
        7.6.2 AstraZeneca Major Business
        7.6.3 AstraZeneca Inactivated Influenza Vaccine Product and Services
        7.6.4 AstraZeneca Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 AstraZeneca Recent Developments/Updates
        7.6.6 AstraZeneca Competitive Strengths & Weaknesses
    7.7 Sinovac Biotech
        7.7.1 Sinovac Biotech Details
        7.7.2 Sinovac Biotech Major Business
        7.7.3 Sinovac Biotech Inactivated Influenza Vaccine Product and Services
        7.7.4 Sinovac Biotech Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Sinovac Biotech Recent Developments/Updates
        7.7.6 Sinovac Biotech Competitive Strengths & Weaknesses
    7.8 Aleph Biomedical
        7.8.1 Aleph Biomedical Details
        7.8.2 Aleph Biomedical Major Business
        7.8.3 Aleph Biomedical Inactivated Influenza Vaccine Product and Services
        7.8.4 Aleph Biomedical Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Aleph Biomedical Recent Developments/Updates
        7.8.6 Aleph Biomedical Competitive Strengths & Weaknesses
    7.9 Abbott Laboratories
        7.9.1 Abbott Laboratories Details
        7.9.2 Abbott Laboratories Major Business
        7.9.3 Abbott Laboratories Inactivated Influenza Vaccine Product and Services
        7.9.4 Abbott Laboratories Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Abbott Laboratories Recent Developments/Updates
        7.9.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.10 Novartis International
        7.10.1 Novartis International Details
        7.10.2 Novartis International Major Business
        7.10.3 Novartis International Inactivated Influenza Vaccine Product and Services
        7.10.4 Novartis International Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis International Recent Developments/Updates
        7.10.6 Novartis International Competitive Strengths & Weaknesses
    7.11 Changchun Institute of Biological
        7.11.1 Changchun Institute of Biological Details
        7.11.2 Changchun Institute of Biological Major Business
        7.11.3 Changchun Institute of Biological Inactivated Influenza Vaccine Product and Services
        7.11.4 Changchun Institute of Biological Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Changchun Institute of Biological Recent Developments/Updates
        7.11.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.12 BCHT
        7.12.1 BCHT Details
        7.12.2 BCHT Major Business
        7.12.3 BCHT Inactivated Influenza Vaccine Product and Services
        7.12.4 BCHT Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 BCHT Recent Developments/Updates
        7.12.6 BCHT Competitive Strengths & Weaknesses
    7.13 Jiangsu GDK
        7.13.1 Jiangsu GDK Details
        7.13.2 Jiangsu GDK Major Business
        7.13.3 Jiangsu GDK Inactivated Influenza Vaccine Product and Services
        7.13.4 Jiangsu GDK Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Jiangsu GDK Recent Developments/Updates
        7.13.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.14 KM Biologics
        7.14.1 KM Biologics Details
        7.14.2 KM Biologics Major Business
        7.14.3 KM Biologics Inactivated Influenza Vaccine Product and Services
        7.14.4 KM Biologics Inactivated Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 KM Biologics Recent Developments/Updates
        7.14.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Inactivated Influenza Vaccine Industry Chain
    8.2 Inactivated Influenza Vaccine Upstream Analysis
        8.2.1 Inactivated Influenza Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Inactivated Influenza Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Inactivated Influenza Vaccine Production Mode
    8.6 Inactivated Influenza Vaccine Procurement Model
    8.7 Inactivated Influenza Vaccine Industry Sales Model and Sales Channels
        8.7.1 Inactivated Influenza Vaccine Sales Model
        8.7.2 Inactivated Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Inactivated Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Inactivated Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Inactivated Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Inactivated Influenza Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Inactivated Influenza Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Inactivated Influenza Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World Inactivated Influenza Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World Inactivated Influenza Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Inactivated Influenza Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Inactivated Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Inactivated Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Inactivated Influenza Vaccine Major Market Trends
    Table 13. World Inactivated Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Inactivated Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World Inactivated Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Inactivated Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Inactivated Influenza Vaccine Producers in 2022
    Table 18. World Inactivated Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Inactivated Influenza Vaccine Producers in 2022
    Table 20. World Inactivated Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Inactivated Influenza Vaccine Company Evaluation Quadrant
    Table 22. World Inactivated Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Inactivated Influenza Vaccine Production Site of Key Manufacturer
    Table 24. Inactivated Influenza Vaccine Market: Company Product Type Footprint
    Table 25. Inactivated Influenza Vaccine Market: Company Product Application Footprint
    Table 26. Inactivated Influenza Vaccine Competitive Factors
    Table 27. Inactivated Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Inactivated Influenza Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Inactivated Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Inactivated Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Inactivated Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Inactivated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Inactivated Influenza Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Inactivated Influenza Vaccine Production Market Share (2018-2023)
    Table 37. China Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Inactivated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Inactivated Influenza Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Inactivated Influenza Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Inactivated Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Inactivated Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Inactivated Influenza Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Inactivated Influenza Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Inactivated Influenza Vaccine Production Market Share (2018-2023)
    Table 47. World Inactivated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Inactivated Influenza Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World Inactivated Influenza Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World Inactivated Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Inactivated Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Inactivated Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Inactivated Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Inactivated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Inactivated Influenza Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World Inactivated Influenza Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World Inactivated Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Inactivated Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Inactivated Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Inactivated Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 62. CSL Limited Major Business
    Table 63. CSL Limited Inactivated Influenza Vaccine Product and Services
    Table 64. CSL Limited Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. CSL Limited Recent Developments/Updates
    Table 66. CSL Limited Competitive Strengths & Weaknesses
    Table 67. GSK Basic Information, Manufacturing Base and Competitors
    Table 68. GSK Major Business
    Table 69. GSK Inactivated Influenza Vaccine Product and Services
    Table 70. GSK Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. GSK Recent Developments/Updates
    Table 72. GSK Competitive Strengths & Weaknesses
    Table 73. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 74. Sanofi Pasteur Major Business
    Table 75. Sanofi Pasteur Inactivated Influenza Vaccine Product and Services
    Table 76. Sanofi Pasteur Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Sanofi Pasteur Recent Developments/Updates
    Table 78. Sanofi Pasteur Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Inactivated Influenza Vaccine Product and Services
    Table 82. Viatris Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. Hualan Biological Basic Information, Manufacturing Base and Competitors
    Table 86. Hualan Biological Major Business
    Table 87. Hualan Biological Inactivated Influenza Vaccine Product and Services
    Table 88. Hualan Biological Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Hualan Biological Recent Developments/Updates
    Table 90. Hualan Biological Competitive Strengths & Weaknesses
    Table 91. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 92. AstraZeneca Major Business
    Table 93. AstraZeneca Inactivated Influenza Vaccine Product and Services
    Table 94. AstraZeneca Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. AstraZeneca Recent Developments/Updates
    Table 96. AstraZeneca Competitive Strengths & Weaknesses
    Table 97. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
    Table 98. Sinovac Biotech Major Business
    Table 99. Sinovac Biotech Inactivated Influenza Vaccine Product and Services
    Table 100. Sinovac Biotech Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Sinovac Biotech Recent Developments/Updates
    Table 102. Sinovac Biotech Competitive Strengths & Weaknesses
    Table 103. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
    Table 104. Aleph Biomedical Major Business
    Table 105. Aleph Biomedical Inactivated Influenza Vaccine Product and Services
    Table 106. Aleph Biomedical Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Aleph Biomedical Recent Developments/Updates
    Table 108. Aleph Biomedical Competitive Strengths & Weaknesses
    Table 109. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 110. Abbott Laboratories Major Business
    Table 111. Abbott Laboratories Inactivated Influenza Vaccine Product and Services
    Table 112. Abbott Laboratories Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Abbott Laboratories Recent Developments/Updates
    Table 114. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 115. Novartis International Basic Information, Manufacturing Base and Competitors
    Table 116. Novartis International Major Business
    Table 117. Novartis International Inactivated Influenza Vaccine Product and Services
    Table 118. Novartis International Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Novartis International Recent Developments/Updates
    Table 120. Novartis International Competitive Strengths & Weaknesses
    Table 121. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 122. Changchun Institute of Biological Major Business
    Table 123. Changchun Institute of Biological Inactivated Influenza Vaccine Product and Services
    Table 124. Changchun Institute of Biological Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Changchun Institute of Biological Recent Developments/Updates
    Table 126. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 127. BCHT Basic Information, Manufacturing Base and Competitors
    Table 128. BCHT Major Business
    Table 129. BCHT Inactivated Influenza Vaccine Product and Services
    Table 130. BCHT Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. BCHT Recent Developments/Updates
    Table 132. BCHT Competitive Strengths & Weaknesses
    Table 133. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 134. Jiangsu GDK Major Business
    Table 135. Jiangsu GDK Inactivated Influenza Vaccine Product and Services
    Table 136. Jiangsu GDK Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Jiangsu GDK Recent Developments/Updates
    Table 138. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 139. KM Biologics Major Business
    Table 140. KM Biologics Inactivated Influenza Vaccine Product and Services
    Table 141. KM Biologics Inactivated Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 142. Global Key Players of Inactivated Influenza Vaccine Upstream (Raw Materials)
    Table 143. Inactivated Influenza Vaccine Typical Customers
    Table 144. Inactivated Influenza Vaccine Typical Distributors
List of Figure
    Figure 1. Inactivated Influenza Vaccine Picture
    Figure 2. World Inactivated Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Inactivated Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Inactivated Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 5. World Inactivated Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Inactivated Influenza Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Inactivated Influenza Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Inactivated Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe Inactivated Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 10. China Inactivated Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan Inactivated Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 12. Inactivated Influenza Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World Inactivated Influenza Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India Inactivated Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Inactivated Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Influenza Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Influenza Vaccine Markets in 2022
    Figure 26. United States VS China: Inactivated Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Inactivated Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Inactivated Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Inactivated Influenza Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Inactivated Influenza Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Inactivated Influenza Vaccine Production Market Share 2022
    Figure 32. World Inactivated Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Inactivated Influenza Vaccine Production Value Market Share by Type in 2022
    Figure 34. Trivalent Influenza Vaccine
    Figure 35. Quadrivalent Influenza Vaccine
    Figure 36. World Inactivated Influenza Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Inactivated Influenza Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Inactivated Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Inactivated Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Inactivated Influenza Vaccine Production Value Market Share by Application in 2022
    Figure 41. Children
    Figure 42. Adolescence
    Figure 43. Adults
    Figure 44. Elderly
    Figure 45. World Inactivated Influenza Vaccine Production Market Share by Application (2018-2029)
    Figure 46. World Inactivated Influenza Vaccine Production Value Market Share by Application (2018-2029)
    Figure 47. World Inactivated Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Inactivated Influenza Vaccine Industry Chain
    Figure 49. Inactivated Influenza Vaccine Procurement Model
    Figure 50. Inactivated Influenza Vaccine Sales Model
    Figure 51. Inactivated Influenza Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL Limited
GSK
Sanofi Pasteur
Viatris
Hualan Biological
AstraZeneca
Sinovac Biotech
Aleph Biomedical
Abbott Laboratories
Novartis International
Changchun Institute of Biological
BCHT
Jiangsu GDK
KM Biologics

Related Reports

Global Inactivated Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Inactivated Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 01 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inactivated Influenza Vaccine market size was valued at USD 7192.4 million in 2022 and is forecast to a readjusted size of USD 10170 million by 2029 with a CAGR of 5.1% during review period.

Global Inactivated Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Inactivated Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inactivated Influenza Vaccine market size was valued at USD 7192.4 million in 2023 and is forecast to a readjusted size of USD 10170 million by 2030 with a CAGR of 5.1% during review period.

Product Tags

Trivalent Inactivated Influenza Vaccine

Inactivated Influenza Vaccine

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>